{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:15:35Z","timestamp":1785374135226,"version":"3.55.0"},"reference-count":242,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104810"],"award-info":[{"award-number":["82104810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e39176","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T11:16:24Z","timestamp":1728731784000},"page":"e39176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8694-893X","authenticated-orcid":false,"given":"Shihao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7903","key":"10.1016\/j.heliyon.2024.e39176_bib1","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/d41586-022-00811-2","article-title":"Hepatitis B","volume":"603","author":"Brody","year":"2022","journal-title":"Nature"},{"issue":"10381","key":"10.1016\/j.heliyon.2024.e39176_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.35772\/ghm.2023.01065","article-title":"Biology of the hepatitis B virus (HBV) core and capsid assembly modulators (CAMs) for chronic hepatitis B (CHB) cure","volume":"5","author":"McFadden","year":"2023","journal-title":"Glob Health Med"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.21037\/tcr-23-1240","article-title":"Spatial epidemiological analysis of the burden of liver cancer in China","volume":"13","author":"Meng","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12889-023-17263-6","article-title":"Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States","volume":"24","author":"Toumi","year":"2024","journal-title":"BMC Publ. Health"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29405","article-title":"Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China","volume":"96","author":"Li","year":"2024","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39176_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4503","article-title":"The next step in controlling HBV in China","volume":"347","author":"Xu","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/apt.16125","article-title":"Review article: current gaps and opportunities in HBV prevention, testing and linkage to care in the United States-a call for action","volume":"53","author":"Yeo","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e39176_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106856","article-title":"Conventional dendritic cells 2, the targeted antigen-presenting-cell, induces enhanced type 1 immune responses in mice immunized with CVC1302 in oil formulation","volume":"267","author":"Du","year":"2024","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41590-023-01517-x","article-title":"CD4(+) T cell calibration of antigen-presenting cells optimizes antiviral CD8(+) T cell immunity","volume":"24","author":"Gressier","year":"2023","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cgh.2019.07.010","article-title":"Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries","volume":"18","author":"Hou","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e39176_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16162878","article-title":"Long-term trends of liver cancer incidence and mortality in China 1990-2017: a joinpoint and age-period-cohort analysis","volume":"16","author":"Wang","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/infdis\/jiv547","article-title":"Peginterferon is superior to nucleos(t)ide analogues for prevention of hepatocellular carcinoma in chronic hepatitis B","volume":"213","author":"Liang","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2016.08.022","article-title":"Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B","volume":"66","author":"Lai","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12072-020-10031-3","article-title":"Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients","volume":"14","author":"Sou","year":"2020","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24437","article-title":"Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: a systematic review and meta-analysis","volume":"10","author":"Tu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13020-023-00861-2","article-title":"The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges","volume":"18","author":"Ge","year":"2023","journal-title":"Chin. Med."},{"issue":"Pt 1","key":"10.1016\/j.heliyon.2024.e39176_bib23","article-title":"The effect and mechanism of Qingre Huashi formula in the treatment of chronic hepatitis B with Gan-dan-shi-Re syndrome: an integrated transcriptomic and targeted metabolomic analysis","volume":"319","author":"Lu","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39176_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28979","article-title":"Traditional Chinese medicine invigorating the spleen and kidney promotes HBsAg seroclearance in the mouse model","volume":"95","author":"Zeng","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e39176_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1110765","article-title":"JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens","volume":"11","author":"Hu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib73","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e39176_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116082","article-title":"Toll-like receptor signalling as a cannabinoid target","volume":"222","author":"Cui Sun","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101936","article-title":"B cell activation and autoantibody production in autoimmune diseases","volume":"38","author":"Sun","year":"2024","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib150","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3892\/etm.2022.11701","article-title":"Artesunate regulates the proliferation and differentiation of neural stem cells by activating the JAK-2\/STAT-3 signaling pathway in ischemic stroke","volume":"25","author":"Luan","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000500721","article-title":"Mechanism-based treatment strategies for IBD: cytokines, cell adhesion molecules, JAK inhibitors, gut flora, and more","volume":"4","author":"Schreiner","year":"2019","journal-title":"Inflamm. Intest. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000526056","article-title":"pSTAT1 is activated during the progression of IgA nephropathy","volume":"3","author":"Tao","year":"2023","journal-title":"Glomerular Dis."},{"key":"10.1016\/j.heliyon.2024.e39176_bib31","article-title":"Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders","volume":"183","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13045-021-01214-y","article-title":"STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer","volume":"14","author":"Awasthi","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib37","article-title":"Interferon and interferon-stimulated genes in HBV treatment","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and hepatitis B: current and future perspectives","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3894816","article-title":"Expression of interferon effector gene SART1 correlates with interferon treatment response against hepatitis B infection","volume":"2016","author":"Li","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39176_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01824-16","article-title":"Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with type I interferon (IFN) receptor 1 to repress IFN\/JAK\/STAT signaling","volume":"91","author":"Chen","year":"2017","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcmgh.2023.10.003","article-title":"Oncostatin M induces IFITM1 expression to inhibit hepatitis B virus replication via JAK-STAT signaling","volume":"17","author":"Ye","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.heliyon.2024.e39176_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117663","article-title":"JAK\/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B","volume":"252","author":"Dong","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12985-021-01544-w","article-title":"The role of SOCS proteins in the development of virus- induced hepatocellular carcinoma","volume":"18","author":"Xie","year":"2021","journal-title":"Virol. J."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e39176_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00196-19","article-title":"Hepatitis B virus precore protein p22 inhibits alpha interferon signaling by blocking STAT nuclear translocation","volume":"93","author":"Mitra","year":"2019","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01557-22","article-title":"IFIT3 is increased in serum from patients with chronic hepatitis B virus (HBV) infection and promotes the anti-HBV effect of interferon alpha via JAK-STAT2 in vitro","volume":"10","author":"Xu","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e39176_bib46","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3748\/wjg.v28.i26.3047","article-title":"Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: a review","volume":"28","author":"Ganguly","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s43440-021-00227-1","article-title":"Pharmacological properties of baicalin on liver diseases: a narrative review","volume":"73","author":"Yang","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jtcme.2023.05.009","article-title":"Baicalin inhibits the replication of the hepatitis B virus by targeting TRIM25","volume":"13","author":"Fan","year":"2023","journal-title":"J Tradit Complement Med"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040900","article-title":"Liver-targeted nanoparticles facilitate the bioavailability and anti-HBV efficacy of baicalin in vitro and in vivo","volume":"10","author":"Xu","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39176_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101514","article-title":"Amygdalin: a review on its characteristics, antioxidant potential, gastrointestinal microbiota intervention, anticancer therapeutic and mechanisms, toxicity, and encapsulation","volume":"12","author":"Barakat","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39176_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26082253","article-title":"Amygdalin: toxicity, anticancer activity and analytical procedures for its determination in plant seeds","volume":"26","author":"Jaszczak-Wilke","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12879-020-05713-0","article-title":"Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2\/STAT3 signaling pathway","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e39176_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115820","article-title":"Tea-break with epigallocatechin gallate derivatives - powerful polyphenols of great potential for medicine","volume":"261","author":"Bakun","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e39176_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.actbio.2021.05.032","article-title":"Epigallocatechin gallate\/L-ascorbic acid-loaded poly-\u03b3-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis","volume":"130","author":"Chiu","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.heliyon.2024.e39176_bib55","article-title":"Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis","volume":"14","author":"He","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41401-019-0302-0","article-title":"ERK1\/2-HNF4\u03b1 axis is involved in epigallocatechin-3-gallate inhibition of HBV replication","volume":"41","author":"Wang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2024.e39176_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116090","article-title":"Preparation methods, structural characteristics, and biological activity of polysaccharides from Salvia miltiorrhiza: a review","volume":"305","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"Pt A","key":"10.1016\/j.heliyon.2024.e39176_bib58","article-title":"Anti-hepatitis B virus activity of lithospermic acid, a polyphenol from Salvia miltiorrhiza, in vitro and in vivo by autophagy regulation","volume":"302","author":"Zhu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib59","article-title":"Lipophilic constituents in Salvia miltiorrhiza inhibit activation of the hepatic stellate cells by suppressing the JAK1\/STAT3 signaling pathway: a network pharmacology study and experimental validation","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12958-022-00949-8","article-title":"Betaine attenuate chronic restraint stress-induced changes in testicular damage and oxidative stress in male mice","volume":"20","author":"Meng","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112946","article-title":"The anti-diabetic potential of betaine. Mechanisms of action in rodent models of type 2 diabetes","volume":"150","author":"Szkudelska","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0954422421000056","article-title":"Effects of betaine on non-alcoholic liver disease","volume":"35","author":"Chen","year":"2022","journal-title":"Nutr. Res. Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/bab.1940","article-title":"Betaine-assisted recombinase polymerase assay for rapid hepatitis B virus detection","volume":"68","author":"Yi","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e39176_bib64","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1021\/acs.jafc.6b01180","article-title":"Betaine inhibits hepatitis B virus with an advantage of decreasing resistance to lamivudine and interferon \u03b1","volume":"64","author":"Zhang","year":"2016","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3892\/etm.2021.10841","article-title":"Immunomodulatory effects of Radix isatidis polysaccharides in vitro and in vivo","volume":"22","author":"Tao","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e39176_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112782","article-title":"Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK\/STAT signal pathway","volume":"257","author":"Wang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115336","article-title":"Inhibition of the pyroptosis-associated inflammasome pathway: the important potential mechanism of ginsenosides in ameliorating diabetes and its complications","volume":"253","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39176_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10465","article-title":"Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion","volume":"8","author":"Duraisamy","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jgr.2022.11.003","article-title":"Antiviral Potential of the Genus Panax: an updated review on their effects and underlying mechanism of action","volume":"47","author":"Zhang","year":"2023","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.heliyon.2024.e39176_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104894","article-title":"Systematic analysis of the mechanism of Xiaochaihu decoction in hepatitis B treatment via network pharmacology and molecular docking","volume":"138","author":"Zeng","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib71","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.3892\/mmr.2017.7561","article-title":"Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2\/STAT3 signaling pathway","volume":"16","author":"Chen","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib74","first-page":"919","article-title":"Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K\/Akt signaling pathway","volume":"43","author":"Hu","year":"2020","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib75","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib76","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1042\/BST20190845","article-title":"Class IA PI3K regulatory subunits: p110-independent roles and structures","volume":"48","author":"Fox","year":"2020","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e39176_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2021.04.007","article-title":"Discovery of novel selective PI3K\u03b3 inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation","volume":"36","author":"Zhu","year":"2022","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib79","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/en.2018-00843","article-title":"PI3K\u03b2-A versatile transducer for GPCR, RTK, and small GTPase signaling","volume":"160","author":"Bresnick","year":"2019","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39176_bib80","first-page":"2321","article-title":"MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K\/AKT\/mTOR signaling pathway","volume":"22","author":"Lv","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib81","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10555-020-09912-8","article-title":"The effects of mutant Ras proteins on the cell signalome","volume":"39","author":"Tak\u00e1cs","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib82","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bcp.13021","article-title":"AKT in cancer: new molecular insights and advances in drug development","volume":"82","author":"Mundi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib83","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","article-title":"Role for Akt3\/protein kinase Bgamma in attainment of normal brain size","volume":"25","author":"Easton","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib84","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/MCB.25.5.1596-1607.2005","article-title":"Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice","volume":"25","author":"Brachmann","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"28","key":"10.1016\/j.heliyon.2024.e39176_bib85","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","article-title":"Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression","volume":"24","author":"Hou","year":"2004","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39176_bib86","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib87","first-page":"4713","article-title":"Role of the PI3K-AKT-mTOR pathway in hepatitis B virus infection and replication","volume":"17","author":"Xiang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e39176_bib88","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1128\/JVI.00541-07","article-title":"Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/labinvest.2011.157","article-title":"HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K\/AKT pathways in chronic hepatitis-B-infected patients","volume":"92","author":"Li","year":"2012","journal-title":"Lab. Invest."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e39176_bib90","doi-asserted-by":"crossref","first-page":"12196","DOI":"10.18632\/oncotarget.2906","article-title":"Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K\/mTOR signaling pathway in liver cells","volume":"6","author":"Zhu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e39176_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8785567","article-title":"HBV infection-related PDZK1 plays an oncogenic role by regulating the PI3K-akt pathway and fatty acid metabolism and enhances immunosuppression","volume":"2022","author":"Chen","year":"2022","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib92","first-page":"163","article-title":"Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology","volume":"13","author":"Su","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e39176_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152871","article-title":"Salvia miltiorrhiza in diabetes: a review of its pharmacology, phytochemistry, and safety","volume":"58","author":"Jia","year":"2019","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042094","article-title":"Antineoplastic activity of 9\u2033-lithospermic acid methyl ester in glioblastoma cells","volume":"25","author":"Tzitiridou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e39176_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106136","article-title":"Matrine counteracts obesity in mice via inducing adipose thermogenesis by activating HSF1\/PGC-1\u03b1 axis","volume":"177","author":"Li","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib96","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/acs.orglett.6b03685","article-title":"Four matrine-based alkaloids with antiviral activities against HBV from the seeds of Sophora alopecuroides","volume":"19","author":"Zhang","year":"2017","journal-title":"Org. Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib97","doi-asserted-by":"crossref","first-page":"329","DOI":"10.29271\/jcpsp.2024.03.329","article-title":"Oxymatrine inhibition of hepatitis B virus replication through ERK1\/2 pathway and HNF1\u03b1 and HNF4\u03b1 block <em>in vitro<\/em&gt","volume":"34","author":"Wang","year":"2024","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e39176_bib98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11010-018-3341-9","article-title":"A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K\/AKT signaling pathways","volume":"449","author":"Sun","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39176_bib99","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1002\/ptr.7186","article-title":"Cordyceps sinensis aqueous extract regulates the adaptive immunity of mice subjected to (60) Co \u03b3 irradiation","volume":"35","author":"Wei","year":"2021","journal-title":"Phytother Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib100","first-page":"1261","article-title":"Cordyceps sinensis attenuates HBx-induced cell apoptosis in HK-2 cells through suppressing the PI3K\/Akt pathway","volume":"45","author":"He","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e39176_bib101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fsi.2022.05.015","article-title":"Yinchenhao Decoction ameliorates the high-carbohydrate diet induced suppression of immune response in largemouth bass (Micropterus salmoides)","volume":"125","author":"Zhao","year":"2022","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108863","article-title":"Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis","volume":"114","author":"Cai","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12906-020-2815-y","article-title":"Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment","volume":"20","author":"Lu","year":"2020","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/19336934.2022.2074783","article-title":"Cell mechanics and cell-cell recognition controls by Toll-like receptors in tissue morphogenesis and homeostasis","volume":"16","author":"Umetsu","year":"2022","journal-title":"Fly"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib107","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e39176_bib108","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00018-020-03453-7","article-title":"Infection and atherosclerosis: TLR-dependent pathways","volume":"77","author":"Li","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e39176_bib109","article-title":"Toll-like receptors in cardiac hypertrophy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12026-022-09290-z","article-title":"Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors","volume":"70","author":"Komal","year":"2022","journal-title":"Immunol. Res."},{"issue":"Pt B","key":"10.1016\/j.heliyon.2024.e39176_bib111","article-title":"Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets","volume":"89","author":"Kumar","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010023","article-title":"Therapeutic targeting of TLR4 for inflammation, infection, and cancer: a perspective for disaccharide lipid A mimetics","volume":"16","author":"Heine","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1389450119666180821105544","article-title":"Toll-like receptor 4 and heat-shock protein 70: is it a new target pathway for diabetic vasculopathies?","volume":"20","author":"de Oliveira","year":"2019","journal-title":"Curr. Drug Targets"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib114","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10863-023-09972-9","article-title":"Toll-like receptor 4 promotes the inflammatory response in septic acute kidney injury by promoting p38 mitogen-activated protein kinase phosphorylation","volume":"55","author":"Yue","year":"2023","journal-title":"J. Bioenerg. Biomembr."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.12.004","article-title":"The oxidation state of cysteine thiols on the ectodomain of TLR2 and TLR4 influences intracellular signaling","volume":"225","author":"Zsengell\u00e9r","year":"2020","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib116","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13041-022-00960-5","article-title":"Toll-like receptors and their role in neuropathic pain and migraine","volume":"15","author":"Liu","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.heliyon.2024.e39176_bib117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","article-title":"Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways","volume":"40","author":"Roy","year":"2016","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e39176_bib118","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7924199","article-title":"Toll-like receptor 4: a promising therapeutic target for alzheimer's disease","volume":"2022","author":"Wu","year":"2022","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib119","first-page":"281","article-title":"Inhibition of TLR4\/TRIF\/IRF3 signaling pathway by curcumin in breast cancer cells","volume":"22","author":"G\u00fcney","year":"2019","journal-title":"J. Pharm. Pharmaceut. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39176_bib120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/17460441.2018.1473372","article-title":"Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections","volume":"13","author":"Du","year":"2018","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e39176_bib121","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.3389\/fmicb.2018.03007","article-title":"Differential expression of woodchuck toll-like receptors 1-10 in distinct forms of infection and stages of hepatitis in experimental hepatitis B virus infection","volume":"9","author":"Williams","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1065","key":"10.1016\/j.heliyon.2024.e39176_bib122","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/postgradmedj-2013-132309","article-title":"TLR9: an important molecule in the fight against hepatitis B virus","volume":"90","author":"Shahrakyvahed","year":"2014","journal-title":"Postgrad. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib123","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clim.2008.04.006","article-title":"Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients","volume":"128","author":"Chen","year":"2008","journal-title":"Clin. Immunol."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e39176_bib124","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798836","article-title":"Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection","volume":"37","author":"Tomasello","year":"2018","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib125","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1142\/S0192415X14500888","article-title":"In vitro immunomodulatory activity of oxymatrine on Toll-like receptor 9 signal pathway in chronic hepatitis B","volume":"42","author":"Yao","year":"2014","journal-title":"Am. J. Chin. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002061","article-title":"Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis","volume":"7","author":"Sitia","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2024.e39176_bib127","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fimmu.2020.00535","article-title":"Hepatitis B core antigen impairs the polarization while promoting the production of inflammatory cytokines of M2 macrophages via the TLR2 pathway","volume":"11","author":"Yi","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12916-021-02085-3","article-title":"HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis","volume":"19","author":"Xie","year":"2021","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib130","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.21897","article-title":"Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice","volume":"46","author":"Wu","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e39176_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965018","article-title":"Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection","volume":"13","author":"Du","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib132","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jep.2017.04.012","article-title":"Hepataprotective effects of ginsenoside Rg1 - a review","volume":"206","author":"Gao","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib133","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12694","article-title":"Ginsenoside Rg1 exerts anti-apoptotic effects on non-alcoholic fatty liver cells by downregulating the expression of SGPL1","volume":"25","author":"Li","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib134","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1139\/cjpp-2015-0528","article-title":"Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in mice","volume":"94","author":"Yuan","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115454","article-title":"Scoping review of the medicinal effects of Eupolyphaga sinensis Walker and the underlying mechanisms","volume":"296","author":"Kim","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116064","article-title":"Active peptides from Eupolyphaga sinensis walker attenuates experimental hyperlipidemia by regulating the gut microbiota and biomarkers in rats with dyslipidemia","volume":"170","author":"Dong","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e39176_bib137","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijbiomac.2020.06.120","article-title":"Characterization of a polysaccharide from Eupolyphaga sinensis walker and its effective antitumor activity via lymphocyte activation","volume":"162","author":"Xie","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib138","article-title":"A polysaccharide from Eupolyphaga sinensis walker with anti-HBV activities in vitro and in vivo","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib139","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","article-title":"Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects","volume":"87","author":"Zhang","year":"2020","journal-title":"Adv. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12272-022-01393-3","article-title":"Astragalus polysaccharide: a review of its immunomodulatory effect","volume":"45","author":"Li","year":"2022","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.heliyon.2024.e39176_bib141","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijbiomac.2019.09.189","article-title":"Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation","volume":"145","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib142","article-title":"Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e39176_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112654","article-title":"A critical review of Astragalus polysaccharides: from therapeutic mechanisms to pharmaceutics","volume":"147","author":"Du","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib144","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1574-695X.2011.00845.x","article-title":"Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor \u03b2 and the frequency of regulatory T cells","volume":"63","author":"Du","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105565","article-title":"Oxymatrine: a current overview of its health benefits","volume":"168","author":"Huan","year":"2023","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib146","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11655-015-2143-0","article-title":"Oral oxymatrine preparation for chronic hepatitis B: a systematic review of randomized controlled trials","volume":"22","author":"Song","year":"2016","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.heliyon.2024.e39176_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110513","article-title":"Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases","volume":"130","author":"Cai","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib148","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12906-023-04146-x","article-title":"Combination of bioaffinity ultrafiltration-UFLC-ESI-Q\/TOF-MS\/MS, in silico docking and multiple complex networks to explore antitumor mechanism of topoisomerase I inhibitors from Artemisiae Scopariae Herba","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.heliyon.2024.e39176_bib149","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6614039","article-title":"A network pharmacology approach to explore the mechanisms of artemisiae scopariae Herba for the treatment of chronic hepatitis B","volume":"2021","author":"He","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39176_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071609","article-title":"RelB and neuroinflammation","volume":"10","author":"Mockenhaupt","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib152","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e39176_bib153","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 Years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39176_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092675","article-title":"Deciphering the role of innate immune NF-\u0138B pathway in pancreatic cancer","volume":"12","author":"Khurana","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e39176_bib155","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","article-title":"Cellular specificity of NF-\u03baB function in the nervous system","volume":"10","author":"Dresselhaus","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39176_bib156","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib157","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e39176_bib158","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20210139","article-title":"Inhibitory feedback control of NF-\u03baB signalling in health and disease","volume":"478","author":"Prescott","year":"2021","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib159","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1039\/D0MD00361A","article-title":"Pharmacological inhibition of NF-\u03baB-inducing kinase (NIK) with small molecules for the treatment of human diseases","volume":"12","author":"Cheng","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e39176_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.730684","article-title":"Interplay between non-canonical NF-\u03baB signaling and hepatitis B virus infection","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib161","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib162","first-page":"81","article-title":"Noncanonical NF-\u03baB signaling pathway in liver diseases","volume":"9","author":"Chen","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.heliyon.2024.e39176_bib163","article-title":"NF-\u03baB inducing kinase regulates intestinal immunity and homeostasis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib164","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.27394","article-title":"Myeloid-specific disruption of recombination signal binding protein J\u03ba ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice","volume":"61","author":"He","year":"2015","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e39176_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134275","article-title":"Progress and prospects of non-canonical NF-\u03baB signaling pathway in the regulation of liver diseases","volume":"27","author":"Tao","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib166","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","article-title":"HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1\u03b2 production via suppressing the NF-\u03baB pathway and ROS production","volume":"66","author":"Yu","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib167","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1080\/22221751.2022.2077128","article-title":"Down-regulated cylindromatosis enhances NF-\u03baB activation and aggravates inflammation in HBV-ACLF patients","volume":"11","author":"Zhang","year":"2022","journal-title":"Emerg. Microb. Infect."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib168","article-title":"Inducers of the NF-\u03baB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro","volume":"4","author":"Michelet","year":"2022","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib169","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12929-019-0534-9","article-title":"Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis","volume":"26","author":"Yen","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"12\u201313","key":"10.1016\/j.heliyon.2024.e39176_bib170","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.molimm.2011.03.012","article-title":"Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-\u03baB","volume":"48","author":"Pan","year":"2011","journal-title":"Mol. Immunol."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e39176_bib171","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3748\/wjg.v20.i23.7197","article-title":"Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity","volume":"20","author":"Jiang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib172","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/15321819.2022.2164507","article-title":"The predictive role of NF-\u03baB-mediated pro-inflammatory cytokine expression levels in hepatitis B vaccine response","volume":"44","author":"Karabay","year":"2023","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.heliyon.2024.e39176_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105406","article-title":"TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity","volume":"207","author":"Tian","year":"2022","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib174","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03785-23","article-title":"Hepatitis B virus evades the immune system by suppressing the NF-\u03baB signaling pathway with DENND2A","volume":"12","author":"Ide","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.heliyon.2024.e39176_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106951","article-title":"Echinacoside: a promising active natural products and pharmacological agents","volume":"197","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e39176_bib176","article-title":"Echinacoside exerts antidepressant-like effects through enhancing BDNF-CREB pathway and inhibiting neuroinflammation via regulating microglia M1\/M2 polarization and JAK1\/STAT3 pathway","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib177","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.17305\/bb.2024.10367","article-title":"Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma","volume":"24","author":"Albalawi","year":"2024","journal-title":"Biomol Biomed"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib178","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s11658-022-00394-w","article-title":"Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery","volume":"27","author":"Wang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib179","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201430R","article-title":"Echinacoside from Cistanche tubulosa ameliorates alcohol-induced liver injury and oxidative stress by targeting Nrf2","volume":"37","author":"Ding","year":"2023","journal-title":"Faseb. J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib180","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3892\/mmr.2020.11201","article-title":"Echinacoside promotes the proliferation of human renal tubular epithelial cells by blocking the HBX\/TREM2-mediated NF-\u03baB signalling pathway","volume":"22","author":"Zhang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39176_bib181","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/nu4121887","article-title":"Immunomodulatory effects of Liriope platyphylla water extract on lipopolysaccharide-activated mouse macrophage","volume":"4","author":"Kim","year":"2012","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e39176_bib182","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virusres.2014.07.015","article-title":"Anti-viral effect of a compound isolated from Liriope platyphylla against hepatitis B virus in vitro","volume":"192","author":"Huang","year":"2014","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib183","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10787-023-01136-w","article-title":"Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.heliyon.2024.e39176_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216332","article-title":"Curcumin in cancer therapy: exploring molecular mechanisms and overcoming clinical challenges","volume":"570","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39176_bib185","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1002\/jcb.26829","article-title":"Effects of curcumin on NF-\u03baB, AP-1, and Wnt\/\u03b2-catenin signaling pathway in hepatitis B virus infection","volume":"119","author":"Hesari","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib186","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29257-1","article-title":"Isosteviol derivative inhibits osteoclast differentiation and ameliorates ovariectomy-induced osteoporosis","volume":"8","author":"Tzeng","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib187","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jfda.2017.09.003","article-title":"Development and validation of an LC-MS\/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies","volume":"26","author":"Kachingwe","year":"2018","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.heliyon.2024.e39176_bib188","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phytochem.2013.12.014","article-title":"Synthesis and antiviral effects of isosteviol-derived analogues against the hepatitis B virus","volume":"99","author":"Huang","year":"2014","journal-title":"Phytochemistry"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39176_bib189","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1021\/acs.jafc.2c06916","article-title":"A comprehensive review on the botany, traditional uses, phytonutrients, health benefits, quality markers, and applications","volume":"71","author":"Ma","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2024.e39176_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113434","article-title":"Ethnomedicinal uses, phytochemistry and dermatological effects of Hippophae rhamnoides L.: a review","volume":"266","author":"Pundir","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib191","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44590-w","article-title":"Hippophae rhamnoides reverses decreased CYP2D6 expression in rats with BCG-induced liver injury","volume":"13","author":"Zou","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib192","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41598-018-38391-9","article-title":"Extracts of Qizhu decoction inhibit hepatitis and hepatocellular carcinoma in vitro and in C57BL\/6 mice by suppressing NF-\u03baB signaling","volume":"9","author":"Wan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e39176_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115965","article-title":"Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis","volume":"303","author":"Jiang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib194","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12906-015-0870-6","article-title":"The Chinese medicine Sini-San inhibits HBx-induced migration and invasiveness of human hepatocellular carcinoma cells","volume":"15","author":"Lin","year":"2015","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.heliyon.2024.e39176_bib195","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8925637","article-title":"Mechanisms of xiaochaihu decoction on treating hepatic fibrosis explored by network pharmacology","volume":"2022","author":"Qiang","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.heliyon.2024.e39176_bib196","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13040-020-00224-9","article-title":"Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease","volume":"13","author":"Hu","year":"2020","journal-title":"BioData Min."},{"key":"10.1016\/j.heliyon.2024.e39176_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116481","article-title":"Inhibiting virus replication and excessive inflammatory response: mechanism of combined prescription of Ma-Xing-Shi-Gan decoction and Xiao-Chai-Hu decoction against influenza virus","volume":"313","author":"Cheng","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152875","article-title":"The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes","volume":"216","author":"Chen","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063322","article-title":"Crosstalk between p38 MAPK and GR signaling","volume":"23","author":"Zeyen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib201","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tplants.2019.11.006","article-title":"MAPK signaling: emerging roles in lateral root formation","volume":"25","author":"He","year":"2020","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.heliyon.2024.e39176_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2018.10.042","article-title":"Kinesins in MAPK cascade: how kinesin motors are involved in the MAPK pathway?","volume":"684","author":"Liang","year":"2019","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39176_bib203","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073572","article-title":"Regulatory mechanisms of mitogen-activated protein kinase cascades in plants: more than sequential phosphorylation","volume":"23","author":"Ma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e39176_bib204","first-page":"3189","article-title":"Skb5, an SH3 adaptor protein, regulates Pmk1 MAPK signaling by controlling the intracellular localization of the MAPKKK Mkh1","volume":"129","author":"Kanda","year":"2016","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10529-020-03042-5","article-title":"The disruption of the MAPKK gene triggering the synthesis of flavonoids in endophytic fungus Phomopsis liquidambaris","volume":"43","author":"Yang","year":"2021","journal-title":"Biotechnol. Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188736","article-title":"E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers","volume":"1877","author":"Park","year":"2022","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e39176_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212595","article-title":"Pseudophosphatases as regulators of MAPK signaling","volume":"22","author":"Hepworth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib208","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/pharmrev.120.000170","article-title":"Regulation of mitogen-activated protein kinase signaling pathways by the ubiquitin-proteasome system and its pharmacological potential","volume":"73","author":"Mathien","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2024.e39176_bib209","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coemr.2020.10.003","article-title":"Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): recent insights using luminescence and fluorescence technologies","volume":"16","author":"Kilpatrick","year":"2021","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"43","key":"10.1016\/j.heliyon.2024.e39176_bib210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303794120","article-title":"Signal transduction at GPCRs: allosteric activation of the ERK MAPK by \u03b2-arrestin","volume":"120","author":"Kahsai","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39176_bib211","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39176_bib212","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1096\/fj.06-6191com","article-title":"Receptor-mediated tobacco toxicity: cooperation of the Ras\/Raf-1\/MEK1\/ERK and JAK-2\/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes","volume":"20","author":"Arredondo","year":"2006","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib213","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41392-023-01329-3","article-title":"Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1\/2","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e39176_bib214","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e39176_bib215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75250","article-title":"MKK6 deficiency promotes cardiac dysfunction through MKK3-p38\u03b3\/\u03b4-mTOR hyperactivation","volume":"11","author":"Romero-Becerra","year":"2022","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib216","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031003","article-title":"p38 signalling pathway","volume":"22","author":"Sanz-Ezquerro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib217","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/med.21574","article-title":"JNK signaling in cancer cell survival","volume":"39","author":"Wu","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib218","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/MMBR.00043-14","article-title":"JNK signaling: regulation and functions based on complex protein-protein partnerships","volume":"80","author":"Zeke","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib219","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040857","article-title":"The JNK signaling pathway in inflammatory skin disorders and cancer","volume":"9","author":"Hammouda","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e39176_bib220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011254","article-title":"MAP kinase pathways","volume":"4","author":"Morrison","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39176_bib221","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1348-0421.2012.00496.x","article-title":"Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase mediated signaling","volume":"56","author":"Jan","year":"2012","journal-title":"Microbiol. Immunol."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e39176_bib222","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1128\/JVI.76.19.9763-9772.2002","article-title":"Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes","volume":"76","author":"Tarn","year":"2002","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib223","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000455954","article-title":"Hepatitis B virus core antigen stimulates IL-6 expression via p38, ERK and NF-\u03baB pathways in hepatocytes","volume":"41","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e39176_bib224","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/labinvest.2016.96","article-title":"Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT\/ERK\/P38 pathway: a possible mechanism of hepatitis B virus persistence","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib225","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jvh.13048","article-title":"Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2","volume":"26","author":"Tian","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39176_bib226","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2019.02.001","article-title":"Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6\/p38 pathway","volume":"511","author":"Hu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39176_bib227","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/1389557521666210913113522","article-title":"Advances in anti-inflammatory activity, mechanism and therapeutic application of ursolic acid","volume":"22","author":"Luan","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib228","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00394-021-02632-x","article-title":"Multi-omics integration reveals the hepatoprotective mechanisms of ursolic acid intake against chronic alcohol consumption","volume":"61","author":"Yan","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.heliyon.2024.e39176_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106306","article-title":"Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer","volume":"182","author":"Li","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39176_bib230","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/jf1045624","article-title":"Suppression of hepatitis B virus x protein-mediated tumorigenic effects by ursolic Acid","volume":"59","author":"Wu","year":"2011","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39176_bib231","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/01480545.2018.1523187","article-title":"Protocatechuic acid protects against menadione-induced liver damage by up-regulating nuclear erythroid-related factor 2","volume":"43","author":"Ibitoye","year":"2020","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib232","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lfs.2017.05.015","article-title":"Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1\/2 pathway and down-regulating HNF4\u03b1 and HNF1\u03b1 in vitro","volume":"180","author":"Dai","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e39176_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114914","article-title":"Research progress of matrine's anticancer activity and its molecular mechanism","volume":"286","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39176_bib234","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1080\/21655979.2021.2024957","article-title":"Novel protein kinase C phosphorylated kinase inhibitor-matrine suppresses replication of hepatitis B virus via modulating the mitogen-activated protein kinase signal","volume":"13","author":"Zhou","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib235","doi-asserted-by":"crossref","DOI":"10.1080\/15502783.2023.2224751","article-title":"Effects of fucoidan supplementation on inflammatory and immune response after high-intensity exercise","volume":"20","author":"McFadden","year":"2023","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib236","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12985-017-0848-8","article-title":"Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation","volume":"14","author":"Li","year":"2017","journal-title":"Virol. J."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39176_bib237","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/acs.jnatprod.6b00671","article-title":"Synthesis of C-4-Substituted steviol derivatives and their inhibitory effects against hepatitis B virus","volume":"79","author":"Lin","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.heliyon.2024.e39176_bib238","article-title":"Uncovering the pharmacological mechanisms of gexia-zhuyu formula (GXZY) in treating liver cirrhosis by an integrative pharmacology strategy","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib239","first-page":"100","article-title":"Therapeutic efficacy and safety of Yinzhihuang granules with phototherapy in neonatal pathologic jaundice: an updated systematic review and meta-analysis","author":"Feng","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39176_bib240","article-title":"A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39176_bib241","first-page":"967","article-title":"Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP\/TAZ signaling","volume":"36","author":"Zhao","year":"2021","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.heliyon.2024.e39176_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199273","article-title":"Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway","volume":"339","author":"Wen","year":"2024","journal-title":"Virus Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024152073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024152073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:08:19Z","timestamp":1775729299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024152073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":242,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024152073"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39176","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39176"}}